Tanaka, Yoshihiro https://orcid.org/0000-0002-0300-7924
Sato, Yuta
Ohno, Shinya
Endo, Masahide
Suetsugu, Tomonari
Okumura, Naoki
Matsuhashi, Nobuhisa
Takahashi, Takao
Yoshida, Kazuhiro
Article History
Received: 13 November 2021
Accepted: 1 January 2022
First Online: 9 January 2022
Declarations
:
: Dr. Yoshida reports receipt of grants, personal fees and non-financial support from EA Pharma Co., Ltd., Sanofi, Yakult Honsha Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Merck Serono Co., Ltd. and Novartis Pharma K.K.; and grants from Kyowa Hakko Kirin Co., Ltd. outside of the submitted work. Dr. Tanaka reports receipt of grants from Daiichi Sankyo Co., Ltd. outside of the submitted work. All of the other authors declare that they have no conflicts of interest.
: Informed consent for participation in the study and use of his tissue was obtained from the patient.
: Written informed consent was obtained from the patient for publication of this case report and accompanying images.